Probiotic cell-free supernatants exhibited anti-inflammatory and antioxidant activity on human gut epithelial cells and macrophages stimulated with LPS

Evidence-based Complementary and Alternative Medicine

Volumn 2018, Issue , 2018, Pages

  De Marco, Stefania ^a   Sichetti, Marzia ^a   Muradyan, Diana ^b   Piccioni, Miranda ^a   Traina, Giovanna ^a   Pagiotti, Rita ^a   Pietrella, Donatella ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b YEREVAN STATE MEDICAL UNIVERSITY   (Armenia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PROBIOTIC AGENT; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL STRAIN; CELL VIABILITY; CONTROLLED STUDY; HT-29 CELL LINE; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS REUTERI; LACTOCOCCUS LACTIS; MACROPHAGE; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; SACCHAROMYCES BOULARDII;

EID: 85050274465     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2018/1756308     Document Type: Article

References (57)

1. M. Sanders, "Probiotics: Definition, Sources, Selection, and Uses," Clinical Infectious Diseases, vol. 46, no. 2, pp. S58-S61, 2008
2. A. C. Brown and A. Valiere, "Probiotics and medical nutrition therapy," Nutrition in Clinical Care, vol. 7, no. 2,pp. 56-68, 2004
3. M. Hickson, A. L. D'Souza, N. Muthu et al., "Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: Randomised double blind placebo controlled trial," British Medical Journal, vol. 335, no. 7610, pp. 80-83, 2007
4. B. Sheil, F. Shanahan, and L. O'Mahony, "Probiotic Effects on Inflammatory Bowel Disease," Journal of Nutrition, vol. 137, no. 3, pp. 819S-824S, 2007
5. K.M. Maslowski and C. R.MacKay, "Diet, gutmicrobiota and immune responses," Nature Immunology, vol. 12, no. 1, pp. 5-9, 2011
6. R. H. Mallappa, N. Rokana, R. K. Duary, H. Panwar, V. K. Batish, and S. Grover, "Management of metabolic syndrome through probiotic and prebiotic interventions," Indian Journal of Endocrinology and Metabolism, vol. 16, no. 1, pp. 20-27, 2012
7. W. H. Holzapfel, P. Haberer, J. Snel, U. Schillinger, and J. H. J. Huis , "Overview of gut flora and probiotics," International Journal of FoodMicrobiology, vol. 41, no. 2, pp. 85-101, 1998
8. G. R. Gibson, H. M. Probert, J. Van Loo, R. A. Rastall, and M. B. Roberfroid, "Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics," Nutrition Research Reviews, vol. 17, no. 2, pp. 259-275, 2004
9. D. W. Lescheid, "Probiotics as regulators of inflammation: A review," Functional Foods in Health and Disease, vol. 4, no. 7, pp. 299-311, 2014
10. T. Mitsuoka, "Development of functional foods," Bioscience of Microbiota, Food and Health, vol. 33, no. 3, pp. 117-128, 2014
11. FAO/WHO, Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada, April 30 and May 1, http://www.who .int/foodsafety/publications/fs management/probiotics2/en/1, 2002
12. G. Traina, L. Menchetti, and F. Rappa, "Probiotic mixture Supplementation in the preventivemanagement of trinitrobenzenesulfonic acid-induced inflammation in a murine model," Journal of Biological Regulators and Homeostatic Agents, vol. 30, no. 3, pp. 895-901, 2016
13. M. Bellavia, F. Rappa, M. Lo Bello et al., "Lactobacillus casei and bifidobacterium lactis Supplementation reduces tissue damage of intestinal mucosa and liver after 2, 4, 6-trinitrobenzenesulfonic acid treatment in mice," Journal of Biological Regulators and Homeostatic Agents, vol. 28, no. 2, pp. 251-261, 2014
14. P. S.Hsieh, Y.An, andY. C. Tsai, "Potential of probiotic strains to modulate the inflammatory responses of epithelial and immune cells in vitro," New Microbiologica, vol. 36, no. 2, pp. 167-179, 2013
15. V. Delcenserie, D. Martel, M. Lamoureux, J. Amiot, Y. Boutin, and D. Roy, "Immunomodulatory effects of probiotics in the intestinal tract," Current Issues in Molecular Biology, vol. 10, no. 1, pp. 37-54, 2008
16. O. Gillor, A. Etzion, and M. A. Riley, "The dual role of bacteriocins as anti-and probiotics," Applied Microbiology and Biotechnology, vol. 81, no. 4, pp. 591-606, 2008
17. S. De Marco, M. Piccioni, D. Muradyan, C. Zadra, R. Pagiotti, and D. Pietrella, "Antibiofilm and Antiadhesive Activities of Different Synbiotics," Journal of Probiotics &Health, vol. 5, no. 3, article 1000182, 2017
18. K. Shida and M. Nanno, "Probiotics and immunology: separating the wheat fromthe chaff," Trends in Immunology, vol. 29,no. 11, pp. 565-573, 2008
19. A. Demont, F.Hacini-Rachinel,R. Doucet-Ladeveze et al., "Live and heat-treated probiotics differently modulate IL10 mRNA stabilization and microRNA expression,"The Journal of Allergy and Clinical Immunology, vol. 137, no. 4, pp. 1264-1267, 2016
20. L. Sancineto, M. Piccioni, S. De Marco et al., "Diphenyl diselenide derivatives inhibit microbial biofilm formation involved in wound infection," BMC Microbiology, vol. 16, no. 1, 2016
21. M. S. Blois, "Antioxidant determinations by the use of a stable free radical," Nature, vol. 181, no. 4617, pp. 1199-1200, 1958
22. M. Elmastas, I. Turkekul, L. Ozturk, I. Gulcin, O. Isildak, and H. Y. Aboul-Enein, "Antioxidant activity of two wild edible mushrooms (Morchella vulgaris andMorchella esculanta) from North Turkey," Combinatorial Chemistry &High Throughput Screening, vol. 9, no. 6, pp. 443-448, 2006
23. S. De Marco, M. Piccioni, R. Pagiotti, and D. Pietrella, "Antibiofilm and Antioxidant Activity of Propolis and Bud Poplar Resins versus Pseudomonas aeruginosa," Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 5163575, 11 pages, 2017
24. D. Haller, C. Bode, W. P. Hammes, A. M. A. Pfeifer, E. J. Schiffrin, and S. Blum, "Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures," Gut, vol. 47, no. 1, pp. 79-87, 2000
25. V. Gross, T. Andus, R. Daig, E. Aschenbrenner, J. Scholmerich, and W. Falk, "Regulation of interleukin-8 production in a human colon epithelial cell line (HT-29)," Gastroenterology, vol. 108, no. 3, pp. 653-661, 1995
26. Y. Goto and H. Kiyono, "Epithelial barrier an interface for the cross-communication between gut flora and immune system," Immunological Reviews, vol. 245, no. 1, pp. 147-163, 2012
27. A. Cencic and T. Langerholc, "Functional cell models of the gut and their applications in food microbiology-A review," International Journal of Food Microbiology, vol. 141, pp. S4-S14, 2010
28. S. Giardina, C. Scilironi, A. Michelotti et al., "In Vitro Anti-InflammatoryActivity of SelectedOxalate-Degrading Probiotic Bacteria: Potential Applications in the Prevention and Treatment of Hyperoxaluria," Journal of Food Science, vol. 79, no. 3, pp. M384-M390, 2014
29. K. Falasca, J. Vecchiet, C. Ucciferri, M. di Nicola, C. D'Angelo, andM. Reale, "Effect of probiotic Supplement on cytokine levels in HIV-infected individuals: A preliminary study," Nutrients, vol. 7, no. 10, pp. 8335-8347, 2015
30. T. D. Luerce, A. C. Gomes-Santos, C. S. Rocha et al., "Antiinflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis," Gut Pathogens, vol. 6, no. 1, article 33, 2014
31. M. Griet, H. Zelaya, M. V. Mateos et al., "Soluble factors from Lactobacillus reuteri CRL1098 have anti-inflammatory effects in acute lung injury induced by lipopolysaccharide in mice," PLoS ONE, vol. 9, no. 10, Article ID e110027, 2014
32. S. Sougioultzis, S. Simeonidis, K. R. Bhaskar et al., "Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-B-mediated IL-8 gene expression," Biochemical and Biophysical Research Communications, vol. 343, no. 1, pp. 69-76, 2006
33. D. Dimitrovski, A. Cencic, E.Winkelhausen, and T. Langerholc, "Lactobacillus plantarum extracellular metabolites: In vitro assessment of probiotic effects on normal and cancerogenic human cells," International Dairy Journal, vol. 39, no. 2, pp. 293-300, 2014
34. M.Nakanishi andD.W. Rosenberg, "Multifaceted roles ofPGE2 in inflammation and cancer," Seminars in Immunopathology, vol. 35, no. 2, pp. 123-137, 2013
35. M. Rokavec, M. G. Oner, H. Li et al., "IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis," The Journal of Clinical Investigation, vol. 124, no. 4, pp. 1853-1867, 2014
36. T. Nagasaki, M. Hara, H. Nakanishi, H. Takahashi, M. Sato, and H. Takeyama, "Interleukin-6 released by colon cancerassociated fibroblasts is critical for tumour angiogenesis antiinterleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction," British Journal of Cancer, vol. 110, no. 2, pp. 469-478, 2014
37. J.-M. Otte, R. Mahjurian-Namari, S. Brand, I. Werner, W. E. Schmidt, and F. Schmitz, "Probiotics regulate the expression of COX-2 in intestinal epithelial cells," Nutrition and Cancer, vol. 61, no. 1, pp. 103-113, 2009
38. G. A. Castiblanco, T. Yucel-Lindberg, S. Roos, and S. Twetman, "Effect of Lactobacillus reuteri on Cell Viability and PGE2 Production in Human Gingival Fibroblasts," Probiotics and Antimicrobial Proteins, vol. 9, no. 3, pp. 278-283, 2017
39. J. W. Griffith, C. L. Sokol, and A. D. Luster, "Chemokines and chemokine receptors: positioning cells for host defense and immunity," Annual Review of Immunology, vol. 32, pp. 659-702, 2014
40. L. M. Rocha-Ramirez, R. A. Perez-Solano, S. L. Castanon-Alonso et al., "Probiotic," Journal of Immunology Research, vol. 2017, Article ID 4607491, 14 pages, 2017
41. C. Banks, A. Bateman, R. Payne, P. Johnson, and N. Sheron, "Chemokine expression in IBD.Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease,"TheJournal of Pathology, vol. 199, no. 1, pp. 28-35, 2003
42. N. Mukaida, M. Shiroo, and K. Matsushima, "Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8,"The Journal of Immunology, vol. 143, no. 4, pp. 1366-1371, 1989
43. M. Candela, F. Perna, P. Carnevali et al., "Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells adhesion properties, competition against enteropathogens and modulation of IL-8 production," International Journal of Food Microbiology, vol. 125, no. 3, pp. 286-292, 2008
44. D. Gilroy and R. De Maeyer, "New insights into the resolution of inflammation," Seminars in Immunology, vol. 27, no. 3, pp. 161-168, 2015
45. N. Y Habil, "Probiotic Induce Macrophage Cytokine Production Via Activation of STAT-3 Pathway," Automation, Control and Intelligent Systems, vol. 3, no. 2, p. 1, 2015
46. R. A. Fernando J. Bonilla, "The ProbioticMixture VSL#3 Alters the Morphology and Secretion Profile of Both Polarized and UnpolarizedHumanMacrophages in a Polarization-Dependent Manner," Journal of Clinical &Cellular Immunology, vol. 05, no. 03, 2014
47. A. Moreno LeBlanc, S. Carmen,M. Zurita-Turk et al., "Importance of IL-10 modulation by probiotic microorganisms in gastrointestinal inflammatory diseases," ISRN Gastroenterology, vol. 2011, Article ID 892971, 11 pages, 2011
48. D. M. Rennick and M. M. Fort, "Lessons from genetically engineered animalmodels. XII. IL-10-deficient (IL-10(-/-)mice and intestinal inflammation," American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 278, no. 6, pp. G829-G833, 2000
49. B. Foligne, S. Nutten, C. Grangette et al., "Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria," World Journal of Gastroenterology, vol. 13, no. 2, pp. 236-243, 2007
50. F.Maghsood, A.Mirshafiey,M.M. Farahani,M.H.Modarressi, P. Jafari, andE.Motevaseli, "Dual effectsof cell free supernatants fromlactobacillus acidophilus and lactobacillus rhamnosusGG in regulation of MMP-9 by Up-regulating TIMP-1 and downregulating CD147 in PMA-differentiated THP-1 cells," Cell, vol. 19, no. 4, pp. 559-566, 2018
51. M. Bermudez-Brito, S. Munoz-Quezada, C. Gomez-Llorente et al., "Cell-free culture supernatant of Bifidobacterium breve CNCMI-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation," PLoS ONE, vol. 8, no. 3, Article IDe59370, 2013
52. V. Mishra, C. Shah, N. Mokashe, R. Chavan, H. Yadav, and J. Prajapati, "Probiotics as Potential Antioxidants: A Systematic Review," Journal of Agricultural and Food Chemistry, vol. 63, no. 14, pp. 3615-3626, 2015
53. E. Persichetti, A. De Michele, M. Codini, and G. Traina, "Antioxidative capacity of Lactobacillus fermentum LF31 evaluated invitro by oxygen radical absorbance capacity assay," Nutrition Journal , vol. 30, no. 7-8, pp. 936-938, 2014
54. S. Kapila, and P. Sinha, "Antioxidative and hypocholesterolemic effect of Lactobacillus casei ssp casei (biodefensive properties of lactobacilli)," Indian Journal of Medical Sciences, vol. 60, no. 9, pp. 361-370, 2006
55. C. B. Forsyth, A. Farhadi, S. M. Jakate, Y. Tang, M. Shaikh, and A. Keshavarzian, "Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis," Alcohol, vol. 43, no. 2, pp. 163-172, 2009
56. P.Dahiya, R. Kamal,R. Gupta, R. Bhardwaj,K. Chaudhary, and S. Kaur, "Reactive oxygen species in periodontitis," Journal of Indian Society of Periodontology, vol. 17, no. 4, pp. 411-416, 2013
57. R. K. Duary, V. K. Batish, and S. Grover, "Immunomodulatory activity of two potential probiotic strains in LPS-stimulatedHT-29 cells," Genes &Nutrition, vol. 9, no. 3, 2014